North City Hospital & Neuro Institute Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 16-11-2024
- Paid Up Capital ₹ 5.07 M
as on 16-11-2024
- Company Age 24 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 7.60 Cr
as on 16-11-2024
- Revenue 22.39%
(FY 2023)
- Profit -76.09%
(FY 2023)
- Ebitda -51.41%
(FY 2023)
- Net Worth 3.25%
(FY 2023)
- Total Assets 7.36%
(FY 2023)
About North City Hospital & Neuro Institute
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 5.07 M.
The company has closed loans amounting to ₹7.60 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Amit Poddar and Gita Poddar serve as directors at the Company.
- CIN/LLPIN
U85110WB2000PTC091194
- Company No.
091194
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Feb 2000
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at North City Hospital & Neuro Institute?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amit Poddar  | Managing Director | 23-Feb-2000 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Gita Poddar | Director | 23-Feb-2000 | Current |
Financial Performance of North City Hospital & Neuro Institute.
North City Hospital & Neuro Institute Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 22.39% increase. The company also saw a substantial fall in profitability, with a 76.09% decrease in profit. The company's net worth moved up by a moderate rise of 3.25%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of North City Hospital & Neuro Institute?
In 2023, North City Hospital & Neuro Institute had a promoter holding of 13.97% and a public holding of 86.03%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
North City Diagnostic Centre Private LimitedActive 27 years 1 monthAmit Poddar and Gita Poddar are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 20 May 2016 | ₹7.60 Cr | Satisfied |
How Many Employees Work at North City Hospital & Neuro Institute?
North City Hospital & Neuro Institute has a workforce of 237 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of North City Hospital & Neuro Institute, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped North City Hospital & Neuro Institute's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
